Ticker: CAPR

Capricor Therapeutics, Inc. (NASDAQ: CAPR) - Quick internal update & income-statement highlights What's happening inside * BLA & regulatory: Company completed rolling BLA (Dec 2024); FDA accepted and granted Priority Review. In May 2025 FDA performed PLI and issued Form 483 observations that Capr...